European Journal of Clinical Investigation
译名:欧洲临床研究杂志
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
3-5
2026
影响因子区间
—
平台估算
3%
2025
中国作者发文占比
—
收费
期刊简介:EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.
【译文】EJCI考虑从最复杂的基础分子科学到应用临床和转化研究以及基于证据的医学的任何原创贡献,涵盖广泛的亚专业。EJCI发表与人类生物学和疾病遗传、分子、细胞或生理基础相关的高质量研究报告,以及针对疾病流行、诊断、病程、治疗和预防的研究。我们主要对直接与人类相关的研究感兴趣,但也鼓励提交稳健的体外和动物研究。跨学科工作以及使用创新方法和实验室、临床和流行病学研究方法和技术的组合对期刊有很大兴趣。考虑几种手稿类别(详细描述见下文):社论、原创文章(包括随机临床试验、系统评价和荟萃分析)、评论(叙述性评论)、观点文章(包括辩论、观点和评论);以及致编辑的信。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |